These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 31416549)
41. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma. Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702 [TBL] [Abstract][Full Text] [Related]
42. Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. Cachia D; Elshafeey NA; Kamiya-Matsuoka C; Hatami M; Alfaro-Munoz KD; Mandel JJ; Colen R; DeGroot JF J Neurooncol; 2017 Oct; 135(1):75-81. PubMed ID: 28702781 [TBL] [Abstract][Full Text] [Related]
43. Basic principles of mathematical growth modeling applied to high-grade gliomas: A brief clinical review for clinicians. Cisneros-Sanchez AK; Flores-Alvarez E; Melendez-Mier G; Roldan-Valadez E Neurol India; 2018; 66(6):1575-1583. PubMed ID: 30504543 [TBL] [Abstract][Full Text] [Related]
44. Scaling of the density of state of the weighted Laplacian in the presence of fractal boundaries. Adrover A; Garofalo F Phys Rev E Stat Nonlin Soft Matter Phys; 2010 Feb; 81(2 Pt 2):027202. PubMed ID: 20365679 [TBL] [Abstract][Full Text] [Related]
45. A murine model of targeted infusion for intracranial tumors. Kim M; Barone TA; Fedtsova N; Gleiberman A; Wilfong CD; Alosi JA; Plunkett RJ; Gudkov A; Skitzki JJ J Neurooncol; 2016 Jan; 126(1):37-45. PubMed ID: 26376657 [TBL] [Abstract][Full Text] [Related]
47. Patient-specific parameter estimates of glioblastoma multiforme growth dynamics from a model with explicit birth and death rates. Han LF; Eikenberry S; He CH; Johnson L; Preul MC; Kostelich EJ; Kuang Y Math Biosci Eng; 2019 Jun; 16(5):5307-5323. PubMed ID: 31499714 [TBL] [Abstract][Full Text] [Related]
48. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma. Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347 [TBL] [Abstract][Full Text] [Related]
55. An adaptive semi-implicit finite element solver for brain cancer progression modeling. Tzirakis K; Papanikas CP; Sakkalis V; Tzamali E; Papaharilaou Y; Caiazzo A; Stylianopoulos T; Vavourakis V Int J Numer Method Biomed Eng; 2023 Jul; 39(7):e3734. PubMed ID: 37203371 [TBL] [Abstract][Full Text] [Related]
56. Inverse dynamic finite element-optimization modeling of the brain tumor mass-effect using a variable pressure boundary. Abdolkarimzadeh F; Ashory MR; Ghasemi-Ghalebahman A; Karimi A Comput Methods Programs Biomed; 2021 Nov; 212():106476. PubMed ID: 34715517 [TBL] [Abstract][Full Text] [Related]
57. Three-dimensional nonlinear invisible boundary detection. Petrou M; Kovalev VA; Reichenbach JR IEEE Trans Image Process; 2006 Oct; 15(10):3020-32. PubMed ID: 17022267 [TBL] [Abstract][Full Text] [Related]
58. Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme. Rozental JM; Cohen JD; Mehta MP; Levine RL; Hanson JM; Nickles RJ J Neurooncol; 1993 Jan; 15(1):57-66. PubMed ID: 8384254 [TBL] [Abstract][Full Text] [Related]
59. Benzyl isothiocyanate inhibits human brain glioblastoma multiforme GBM 8401 cell xenograft tumor in nude mice in vivo. Ma YS; Lin JJ; Lin CC; Lien JC; Peng SF; Fan MJ; Hsu FT; Chung JG Environ Toxicol; 2018 Nov; 33(11):1097-1104. PubMed ID: 29972272 [TBL] [Abstract][Full Text] [Related]
60. Repurposing drugs for glioblastoma: From bench to bedside. Basso J; Miranda A; Sousa J; Pais A; Vitorino C Cancer Lett; 2018 Aug; 428():173-183. PubMed ID: 29729291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]